Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812201 · ClinicalTrials.gov registry record
Evaluation of Left Ventricular AutoThreshold
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 80
- Enrollment target
NCT00812201: Completed study, sponsored by Boston Scientific Corporation.
NCT00812201 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00812201 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study will collect data on a new feature for future heart failure devices via an external non-implantable system.
Interventions
- DEVICE No intervention is used. Collection of signals only.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-10 |
What the finished NCT00812201 record still lists
NCT00812201 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is used. Collection of signals only. is the first listed.
NCT00812201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00812201 about?
NCT00812201 is a clinical study titled "Evaluation of Left Ventricular AutoThreshold". This study will collect data on a new feature for future heart failure devices via an external non-implantable system.
What is the current status of trial NCT00812201?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2008-12. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00812201?
The interventions under investigation include: No intervention is used. Collection of signals only. (DEVICE).
Who is sponsoring clinical trial NCT00812201?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia